Related Experiment Video

Updated: May 3, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

23.7K

Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management

Wen Kang1, Hsin-I Tong, Yongtao Sun

  • 1Department of Public Health Sciences, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.

Expert Review of Gastroenterology & Hepatology
|January 24, 2014
PubMed

Insights

Hepatitis C virus (HCV) exacerbates liver disease in HIV-1 patients, with rising acute infections. New direct-acting antivirals offer improved treatment options for these co-infected individuals.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Hepatitis C virus (HCV) significantly increases liver disease morbidity and mortality in individuals with human immunodeficiency virus type 1 (HIV-1).
  • Recent trends show increasing acute HCV infections globally within the HIV-co-infected population.
  • HIV-1 infection accelerates HCV-related liver disease progression, leading to cirrhosis, liver failure, and hepatocellular carcinoma.

Purpose of the Study:

  • To review the challenges and evolving therapeutic strategies for managing HCV/HIV co-infection.
  • To highlight the limitations of current HCV treatments in this population.
  • To discuss emerging treatment options and the role of liver transplantation.

Main Methods:

  • Literature review of HCV/HIV co-infection management.
  • Analysis of treatment outcomes and challenges.
  • Discussion of new direct-acting antiviral agents and transplantation.

Main Results:

  • Standard HCV treatment (pegylated interferon plus ribavirin) shows limited efficacy.
  • Complex drug regimens and potential hepatotoxicity complicate treatment.
  • Emerging direct-acting antiviral agents promise better therapeutic options.

Conclusions:

  • HCV/HIV co-infection presents unique management challenges due to accelerated liver disease progression and treatment complexities.
  • Advancements in direct-acting antivirals are expected to improve outcomes.
  • Liver transplantation is an increasingly viable option for end-stage liver disease in co-infected patients.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.2K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

20.3K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
2.0K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58